Pál Miheller

Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease

László Kiss, Tamás Szamosi, Tamás Molnár et al. · Alimentary Pharmacology & Therapeutics · 2011 · 159 citations · Full text

New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort

Mária Papp, I Altorjay, Nir Dotan et al. · The American Journal of Gastroenterology · 2008 · 146 citations

Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohnʼs disease patients

Pál Miheller, Györgyi Műzes, István Hritz et al. · Inflammatory Bowel Diseases · 2009 · 121 citations · Full text

Inflammation, Adenoma and Cancer: Objective Classification of Colon Biopsy Specimens with Gene Expression Signature

Orsolya Galamb, Balázs Győrffy, Ferenc Sípos et al. · Disease Markers · 2008 · 118 citations · Full text

Detection of Methylated Septin 9 in Tissue and Plasma of Colorectal Patients with Neoplasia and the Relationship to the Amount of Circulating Cell-Free DNA

Kinga Tóth, Reinhold Wasserkort, Ferenc Sípos et al. · PLoS ONE · 2014 · 99 citations · Full text